SLXN (Silexion Therapeutics) Total Equity : $-3.99 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Silexion Therapeutics Total Equity?

Silexion Therapeutics's total equity for the quarter that ended in Dec. 2024 was $-3.99 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Silexion Therapeutics Total Equity Historical Data

The historical data trend for Silexion Therapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silexion Therapeutics Total Equity Chart

Silexion Therapeutics Annual Data

Trend

Dec22

Dec23

Dec24

Total Equity

-7.08

-12.06

-3.99

Silexion Therapeutics Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Equity	Get a 7-Day Free Trial				-12.06	-13.45	-14.90	-4.58	-3.99

Silexion Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Silexion Therapeutics's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	2.863	-	6.852
	=	-3.99

Silexion Therapeutics's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	2.863	-	6.852
	=	-3.99

Silexion Therapeutics Total Equity Related Terms

Thank you for viewing the detailed overview of Silexion Therapeutics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Silexion Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Silexion Therapeutics Corp (NAS:SLXN) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Ha mayan Street, Modi in-Maccabim-Reut, ISR, 7177871

Website

https://www.silexion.com

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.